Literature DB >> 29568987

Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome.

T Harish Varma1, Ashish Sharma1, S Santhiya1, Lesa Dawman1, Karalanglin Tiewsoh2.   

Abstract

Furosemide is one of the most common drug used to treat anasarca in childhood nephrotic syndrome. It has minimal side effects on short-term usage, but prolonged use can result in polyuria, hypokalemia and metabolic alkalosis. This pseudo-bartter complication can be treated by discontinuation of the drug with adequate potassium replacement. We report a child who was given furosemide for 20 days elsewhere to treat the edema due to nephrotic syndrome and then presented to us with bartter-like syndrome. Furosemide was discontinued and potassium replacement was initiated. However, the child continued to have polyuria leading to repeated episodes of hypotensive shock. In view of severe symptoms, she was given a short course of oral indomethacin for 6 days, to which she responded. This case highlights the fact that indomethacin can provide symptomatic improvement in furosemide induced pseudo-bartter.

Entities:  

Keywords:  Furosemide; Indomethacin; Metabolic alkalosis; Potassium; Pseudo bartter syndrome

Mesh:

Substances:

Year:  2018        PMID: 29568987      PMCID: PMC6181891          DOI: 10.1007/s13730-018-0324-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  12 in total

1.  Mimicry of surreptitious diuretic ingestion and the ability to make a genetic diagnosis.

Authors:  H Schepkens; H Hoeben; R Vanholder; N Lameire
Journal:  Clin Nephrol       Date:  2001-03       Impact factor: 0.975

2.  Pseudo-Bartter's syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter's syndrome.

Authors:  G Colussi; G Rombolà; C Airaghi; M E De Ferrari; L Minetti
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

3.  [A case of pseudo-Bartter's syndrome induced by long-term ingestion of furosemide delivered orally through health tea].

Authors:  Atsushi Numabe; Atsuko Ogata; Minoru Abe; Masaki Takahashi; Koichi Kono; Masaru Arakawa; Toshihiko Ishimitsu; Tamio Ieiri; Hiroaki Matsuoka; Shigeru Yagi
Journal:  Nihon Jinzo Gakkai Shi       Date:  2003-07

Review 4.  Bartter's and Gitelman's syndromes: their relationship to the actions of loop and thiazide diuretics.

Authors:  Robert J Unwin; Giovambattista Capasso
Journal:  Curr Opin Pharmacol       Date:  2006-02-20       Impact factor: 5.547

5.  [Pseudo-Bartter's syndrome induced by surreptitious ingestion of furosemide to lose weight: a case report and possible pathophysiology].

Authors:  H Sasaki; T Kawasaki; T Yamamoto; H Ninomiya; J Ono; T Yamamoto; T Asano; M Okumura; K Kangawa; H Matsuo
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1986-08-20

6.  Indomethacin and atrial natriuretic peptide in pseudo-Bartter's syndrome.

Authors:  H Sasaki; M Okumura; T Kawasaki; K Kangawa; H Matsuo
Journal:  N Engl J Med       Date:  1987-01-15       Impact factor: 91.245

7.  Inhibition of COX-2 counteracts the effects of diuretics in rats.

Authors:  M C Kammerl; R M Nüsing; W Richthammer; B K Krämer; A Kurtz
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

8.  Disposition and diuretic effect of furosemide in the nephrotic syndrome.

Authors:  E Keller; G Hoppe-Seyler; P Schollmeyer
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

Review 9.  Management of edema in nephrotic syndrome.

Authors:  Anil Vasudevan; Mukta Mantan; Arvind Bagga
Journal:  Indian Pediatr       Date:  2004-08       Impact factor: 1.411

10.  Furosemide-induced severe hypokalemia with rhabdomyolysis without cardiac arrest.

Authors:  Wolfgang Ruisz; Claudia Stöllberger; Josef Finsterer; Franz Weidinger
Journal:  BMC Womens Health       Date:  2013-07-09       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.